Cargando…
Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
OBJECTIVE: Despite multiple drugs available, a large proportion of patients with generalized anxiety disorder (GAD) do not show adequate response and remission. Thus, additional novel pharmacological agents are needed to increase treatment option for GAD. We aimed to investigate efficacy and safety...
Autores principales: | Wang, Sheng-Min, Woo, Young Sup, Kim, Nak-Young, Na, Hae-Ran, Lim, Hyun Kook, Bahk, Won-Myong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383014/ https://www.ncbi.nlm.nih.gov/pubmed/32702221 http://dx.doi.org/10.9758/cpn.2020.18.3.423 |
Ejemplares similares
-
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2021) -
Patient Factors Influencing Outpatient Retention in Patients with Affective and Anxiety Disorders: A Retrospective Study
por: Chang, Seyeon, et al.
Publicado: (2021) -
A Comparative Study on the Predictive Value of Different Resting-State Functional Magnetic Resonance Imaging Parameters in Preclinical Alzheimer's Disease
por: Wang, Sheng-Min, et al.
Publicado: (2021) -
Relationship between Delusion of Theft and Cognitive Functions in Patients with Mild Alzheimer’s Disease
por: Na, Hae-Ran, et al.
Publicado: (2018) -
Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2020)